Log In
Print
BCIQ
Print
Print this Print this
 

Galafold, migalastat (AT1001) (formerly Amigal)

  Manage Alerts
Collapse Summary General Information
Company Amicus Therapeutics Inc.
DescriptionSmall molecule that enhances alpha galactosidase A activity
Molecular Target Alpha galactosidase A
Mechanism of ActionUndisclosed
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentRegistration
Standard IndicationFabry's disease
Indication DetailsTreat Fabry's disease
Regulatory Designation EU - Accelerated Assessment (Treat Fabry's disease);
EU - Orphan Drug (Treat Fabry's disease);
Japan - Orphan Drug (Treat Fabry's disease)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

$30.0M

$170.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today